[Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].

A Tokunaga, Masahiko Onda, T Mizutani, Masatoshi Miyamoto, Tomohisa Nomura, Hideaki Hayashi, Teruo Kiyama, Makoto Umehara, Koji Nishi, Tatsumasa AndohPubMed 1989

Abstract

Fourteen patients with advanced gastric cancer consisting of seven primary cases and seven recurrent cases were treated with the combination of etoposide, adriamycin and cisplatin (EAP). One of the primary cases (14%) and three of the recurrent cases (43%) responded to the therapy, but a high incidence of toxicities including leukopenia, thrombocytopenia, alopecia, nausea and vomiting was observed. It is concluded that EAP therapy can be useful in the treatment of advanced gastric cancer if countermeasures to the toxicities of these drugs are considered.
BibTeX
@inproceedings{tokunaga1989combination,
  author = {A Tokunaga and Masahiko Onda and T Mizutani and Masatoshi Miyamoto and Tomohisa Nomura and Hideaki Hayashi and Teruo Kiyama and Makoto Umehara and Koji Nishi and Tatsumasa Andoh},
  title = {{[Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].}},
  booktitle = {PubMed},
  year = {1989},
}

Loading related content...

Figure